CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Reckitt Benckiser Pharmaceuticals Inc. v. Par Pharmaceutical Inc.

1:13-cv-01461

Overview

Case Number 1:13-cv-01461
Filing Date 2013-08-20
Status Terminated
Termination Date 2014-05-27
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

LTS Lohmann Therapy Systems Corp. Operating Company

Represented By

1 Attorneys Listed

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Par Pharmaceutical Inc. Operating Company

Represented By

6 Attorneys Listed

Daniel G. Brown

Email: daniel.brown@lw.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Jennifer R. Saionz

UNDELIVERABLE EMAIL 6/11/14

Emily C. Melvin

UNDELIVERABLE EMAIL 5/18/17

James K. Lynch

Email: jim.lynch@lw.com

Counter Claimant

IntelGenX Technologies Corp. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Counter Defendant

MonoSol Rx LLC Operating Company

Represented By

5 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Timothy C. Bickham

Email: tbickham@steptoe.com

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

James F. Hibey

Email: jhibey@steptoe.com

Houda Morad

UNDELIVERABLE EMAIL 4/1/15

RB Pharmaceuticals Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Reckitt Benckiser Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

James M. Bollinger

Email: james.bollinger@troutman.com

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Timothy P. Heaton

UNDELIVERABLE EMAIL 6/1/20

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Daniel A. Ladow

UNDELIVERABLE EMAIL 11/3/2020

Troy S. Kleckley

UNDELIVERABLE EMAIL 11/3/2020

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 10 proceedings
🏛️
USPTO PTAB Trials 10 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (1): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (20 found):
PTAB: 10 U.S. Courts: 10
USPTO PTAB Trial 2017-06-12
IPR2017-01582

Dr. Reddy’s Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.

U.S. Continuation Sibling (8603514)
Status: Institution Denied
USPTO PTAB Trial 2017-06-09
IPR2017-01557

Par Pharmaceutical, Inc. et al. v. MonoSol Rx, LLC et al.

U.S. Continuation Sibling (8603514)
Status: Institution Denied
USPTO PTAB Trial 2016-11-04
IPR2017-00200

Mylan Technologies, Inc. et al. v. MonoSol Rx, LLC et al.

U.S. Continuation Sibling (8603514)
Status: Terminated-Settled
USPTO PTAB Trial 2016-05-31
IPR2016-01113

Dr. Reddy’s Laboratories, Inc. et al. v. Indivior UK Limited et al.

U.S. Continuation Sibling (8475832)
Status: Institution Denied
USPTO PTAB Trial 2016-05-31
IPR2016-01112

Dr. Reddy’s Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.

U.S. Continuation Sibling (8017150)
Status: Institution Denied
USPTO PTAB Trial 2016-05-31
IPR2016-01111

Dr. Reddy's Laboratories, Inc. et al. v. MonoSol Rx, LLC et al.

U.S. Continuation Sibling (8603514)
Status: Institution Denied
USPTO PTAB Trial 2015-12-04
IPR2016-00282

Teva Parmaceuticals USA Inc. v. MONOSOL RX, LLC et al.

U.S. Continuation Sibling (8017150)
Status: Institution Denied
USPTO PTAB Trial 2015-12-04
IPR2016-00281

Teva Pharmaceuticals USA Inc v. MONOSOL RX LLC et al.

U.S. Continuation Sibling (8603514)
Status: Institution Denied
USPTO PTAB Trial 2015-12-03
IPR2016-00280

Teva Pharmaceuticals USA, Inc. v. Indivior UK Limited et al.

U.S. Continuation Sibling (8475832)
Status: Institution Denied
USPTO PTAB Trial 2014-06-20
IPR2014-00998

BioDelivery Sciences International, Inc. v. RB Pharmaceuticals Limited

U.S. Continuation Sibling (8475832)
Status: Institution Denied
U.S. District Court 2019-11-11
5:19-cv-00505

Aquestive Therapeutics, Inc. v. BioDelivery Sciences International, Inc.

U.S. Family Sibling (["US8765167", "US5881476", "US5393528", "US7425292", "US8603514", "US8900497", "US9931305"])
Status: NCED
U.S. District Court 2016-10-31
1:16-cv-01009

Indivior Inc. v. Actavis Laboratories UT, Inc.

U.S. Family Sibling (["US8475832", "US8017150", "US8603514"])
Status: DED
U.S. District Court 2016-03-21
1:16-cv-00178

Indivior Inc. v. Teva Pharmaceuticals USA, Inc.

U.S. Family Sibling (["US8475832", "US8017150", "US8603514", "US8900497", "US8906277"])
Status: DED
U.S. District Court 2015-11-04
1:15-cv-01016

Indivior Inc. v. Mylan Technologies Inc.

U.S. Family Sibling (["US8475832", "US8017150", "US8603514"])
Status: DED
U.S. District Court 2015-07-21
5:15-cv-00350

Indivior Inc. v. Biodelivery Sciences International, Inc.

U.S. Family Sibling (["US8765167", "US8663687", "US5881476", "US5393528", "US7425292", "US8603514", "US8900497", "US9931305"])
Status: NCED
U.S. District Court 2015-06-10
1:15-cv-00477

Indivior Inc. v. Alvogen Pine Brook LLC

U.S. Family Sibling (["US8475832", "US8017150", "US8603514", "US8900497", "US8906277"])
Status: DED
U.S. District Court 2014-12-02
1:14-cv-01451

Indivior, Inc. v. Dr. Reddy's Laboratories S.A.

U.S. Family Sibling (["US8475832", "US8017150", "US8603514", "US8900497", "US8906277"])
Status: DED
U.S. District Court 2014-09-20
5:14-cv-00529

BioDelivery Sciences International, Inc. v. Reckitt Benckiser Pharmaceuticals, Inc.

U.S. Family Sibling (["US8475832", "US7897080", "US8652378"])
Status: NCED
U.S. District Court 2014-04-04
1:14-cv-00422

Reckitt Benckiser Pharmaceuticals Inc. v. Par Pharmaceutical Inc.

U.S. Family Sibling (["US8475832", "US8017150", "US8603514"])
Status: DED
U.S. District Court 2013-12-06
1:13-cv-02003

Reckitt Benckiser Pharmaceuticals Inc. v. Alvogen Pine Brook Inc

U.S. Family Sibling (["US8475832", "US8017150", "US8603514"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8170150
Digitally controlled phase interpolator circuit
Filed: 2008-03-21
Issued: 2012-05-01
Active (2.9 yrs remaining) +590d PTA
Expires: 2029-11-01
US8475832
Sublingual and buccal film compositions
Filed: 2009-08-07
Issued: 2013-07-02
Active (3.3 yrs remaining) +231d PTA
Expires: 2030-03-26
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
Filed: 2008-04-22
Issued: 2011-09-13
Expired (Term Ended)
Expires: 2023-10-10
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Filed: 2007-07-10
Issued: 2013-12-10
Expired (Term Ended)
Expires: 2024-04-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+590 days) / Cellect Scrutiny — Over 590 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

18

Dispositive

6

Granted

2

Denied

0

Pending / Review

8

Motions by Category

Procedural / Extension Motion 11 Claim Construction / Markman Filing 1 Motion to Dismiss 6

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER Granting 81 MOTION to Dismiss the Amended Complaint and Counterclaims. Signed by Judge Richard G. Andrews on 5/27/2014. (nms) (Entered: 05/27/2014)
Entry #92 • 2014-05-27 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 81 MOTION to Dismiss the Amended Complaint and Counterclaims, filed by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceutic...
Entry #91 • 2014-05-14 Document →
Motion to Dismiss Pending
MOTION to Dismiss the Amended Complaint and Counterclaims - filed by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals Inc.. (Attach...
Entry #81 • 2014-04-17 Document →
Motion to Dismiss Granted
MOTION to Dismiss the Amended Complaint and Counterclaims - filed by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals Inc.. (Attach...
Entry #81 • 2014-04-17 Document →
Motion to Dismiss Pending / Under Review
[SEALED] OPENING BRIEF in Support re 81 MOTION to Dismiss to Dismiss the Amended Complaint and Counterclaims, filed by MonoSol Rx LLC, RB Pharmaceuticals Limite...
Entry #82 • 2014-04-17 Document →
Motion to Dismiss Pending / Under Review
[SEALED] DECLARATION of Dana K. Severance re 81 MOTION to Dismiss the Amended Complaint and Counterclaims, by MonoSol Rx LLC, RB Pharmaceuticals Limited, Reckit...
Entry #83 • 2014-04-17 Document →

Docket Entries

(167 total)
Pleading / Complaint

COMPLAINT filed against IntelGenX Technologies Corp., LTS Lohmann Therapy Systems Corp., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1351905.) - filed by Reckitt Benckiser Pharmaceuticals Inc., RB Pharmaceuticals Limited, MonoSol Rx LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 08/20/2013)

Entry #1 • 2013-08-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 08/20/2013)

Entry #2 • 2013-08-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/10/2013. Date of Expiration of Patent: 8,170,150:2/13/2023; 8,475,832:3/26/2030.Thirty Month Stay Deadline: 1/10/2016. (dmp, ) (Entered: 08/20/2013)

Entry #3 • 2013-08-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,475,832; US 8,017,150;. (dmp, ) (Entered: 08/20/2013)

Entry #4 • 2013-08-20
1

Disclosure Statement pursuant to Rule 7.1 filed by MonoSol Rx LLC. (dmp, ) (Entered: 08/20/2013)

Entry #5 • 2013-08-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc